Delivery Order SPE2DB25D3001-SPE2DB25FQUBP

Award Date 2/27/25
Potential Completion Date 2/28/25
Potential Value $15K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $42,641.71, is for the delivery of VAXNEUVANCE 0.5 ML SYRINGE 0.5ML, a medical supply. The contract is a Delivery Order with a Firm Fixed Price pricing type, with a completion date of September 25, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC)...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,124.60, is for the delivery of VAXNEUVANCE 0.5 ML SYRINGE 0.5ML medical supplies. The contract type is a Delivery Order with a Firm Fixed Price pricing mechanism, and the ultimate completion date is May 30, 2024. The contract is not designated with a set-aside requirement....
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,370.39, is a Firm Fixed Price Delivery Order for the supply of VAXNEUVANCE 0.5 ML SYRINGE 0.5ML, a medical product. The contract has a period of performance through January 31, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,917.60 Firm Fixed Price delivery order is for the supply of VAXNEUVANCE 0.5 ML SYRINGE 0.5ML, a pharmaceutical product. The contract has an ultimate completion date of February 27, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The $66,637.09 firm fixed-price delivery order is for the supply of VAXNEUVANCE 0.5 ML SYRINGE 0.5ML, a medical product. The contract has an ultimate completion date of February 25, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,842.45 firm fixed-price delivery order is for the supply of VAXNEUVANCE 0.5 ML SYRINGE 0.5ML, a vaccine product. The contract has an ultimate completion date of December 10, 2024. AmerisourceBergen holds a substantial Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of VAXNEUVANCE 0.5 ML SYRINGE 0.5ML, a pharmaceutical product, with a firm fixed price of $2,727.44 and an ultimate completion date of May 1, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a single-award Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of VAXNEUVANCE 0.5 ML SYRINGE 0.5ML medical supplies. The contract has a ceiling value of $8,069.52 and is a Firm Fixed Price Delivery Order without any set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $41,577.47, is for the supply of VAXNEUVANCE 0.5 ML SYRINGE 0.5ML medical products. The contract has a firm fixed price pricing type and an ultimate completion date of January 17, 2025. AmerisourceBergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,665.67 firm-fixed-price delivery order is for the supply of VAXNEUVANCE 0.5 ML SYRINGE 0.0.5ML, a medical product, with a period of performance through November 13, 2024. The award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) between AmerisourceBergen and the...
  • SPE2DB25D3001
    Indefinite Delivery Contract
  • SPE2DB25D3001-SPE2DB25FQUBP
    Delivery Order

This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of VAXNEUVANCE 0.5 ML SYRINGE 0.5ML, a medical product. The contract is a Delivery Order with a Firm Fixed Price of $15,031.03 and a performance period ending on February 28, 2025. Amerisourcebergen also holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award does not have a set-aside designation, indicating open competition.

Generated 6/1/25, 3:20 AM